Atosiban

From Wikipedia, the free encyclopedia

Atosiban
Systematic (IUPAC) name
1-(3-mercaptopropanoic acid)- 2-(O-ethyl-D-tyrosine)-4-L-threonine- 8-L-ornithine-oxytocin
Identifiers
CAS number	90779-69-4
ATC code	G02CX01
PubChem	68613
Chemical data
Formula	C43H67N11O12S2
Mol. weight	994.199
Pharmacokinetic data
Bioavailability	?
Metabolism	?
Half life	?
Excretion	?
Therapeutic considerations
Pregnancy cat.	?
Legal status
Routes	intravenous

Atosiban (Tractocile® or Antocin®, RWJ 22164) is an inhibitor of the hormones oxytocin and vasopressin, and is used intravenously in premature labor. Although initial studies suggested it could be used as a nasal spray and hence would not require hospital admission, it is not used in that form. It was developed by Ferring Pharmaceuticals in Sweden and first reported in the literature by Akerlund et al in 1985.

Chemically, it is a modified form of oxytocin that inhibits the action of this hormone on the uterus, leading to a cessation of contractions. It is therefore a tocolytic.

[edit] Reference

• Akerlund M, Carlsson AM, Melin P, Trojnar J. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand 1985;64(6):499-504. PMID 4061066.